Submit your email to push it up the queue
Sanofi Pasteur SA, a leading global player in the vaccine industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 2004 as the vaccines division of Sanofi, the company has a rich history of innovation and commitment to public health, with key milestones including the development of vaccines for diseases such as influenza and meningitis. Specialising in the research, development, and production of vaccines, Sanofi Pasteur offers a diverse portfolio that includes both paediatric and adult vaccines. Their unique approach combines cutting-edge technology with a focus on safety and efficacy, positioning them as a trusted name in immunisation. With a strong market presence and notable achievements in vaccine distribution, Sanofi Pasteur continues to play a pivotal role in global health initiatives.
How does Sanofi Pasteur SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sanofi Pasteur SA's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sanofi Pasteur SA, headquartered in France, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sanofi, which has established various climate commitments and initiatives aimed at reducing carbon emissions across its operations. While no absolute emissions figures are provided, Sanofi has set ambitious targets through its parent organisation. These include commitments to the Science Based Targets initiative (SBTi), which aims to align corporate emissions reductions with climate science. Sanofi is also involved in the Carbon Disclosure Project (CDP) and has pledged to transition to 100% renewable energy through the RE100 initiative. As a subsidiary, Sanofi Pasteur SA's climate strategies and performance are influenced by the overarching goals set by Sanofi, which include significant reductions in Scope 1, 2, and 3 emissions. However, specific reduction targets or achievements for Sanofi Pasteur SA have not been detailed. In summary, while direct emissions data for Sanofi Pasteur SA is not available, the company is part of a broader corporate commitment to sustainability and climate action through its parent organisation, Sanofi.
Access structured emissions data, company-specific emission factors, and source documents
2010 | 2011 | 2012 | 2013 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi Pasteur SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.